Effectiveness of tax and price policies in tobacco control
Objective
Over 20 experts on economics, epidemiology, public policy and tobacco control were asked by the International Agency for Research on Cancer (IARC) to evaluate the strength of the available evidence on the effects of tax and price policies to prevent and reduce tobacco use.
Methods
Draft papers presenting and assessing the evidence on the following topics were developed by the experts in an 8-month period prior to the meeting: tobacco industry pricing strategies and tax related lobbying; tax, price and aggregate demand for tobacco; tax, price and adult tobacco use, use among young people and use among the poor; tax avoidance and tax evasion; and the economic and health impact of tobacco taxation. Subsequently, papers were peer reviewed, revised and resubmitted for final discussion at a 6-day meeting at IARC in Lyon, France, where a consensus evaluation of 18 concluding statements using the pre-established criteria of the IARC Cancer Prevention Handbooks took place. Studies published (or accepted for publication) in the openly available scientific literature were the main source of evidence for the review and evaluation; other types of publications were included when appropriate.
Results
In support of 12 of the 18 conclusions, the experts agreed that there was sufficient evidence of effectiveness of increased tobacco excise taxes and prices in reducing overall tobacco consumption and prevalence of tobacco use and improvement of public health, including by preventing initiation and uptake among young people, promoting cessation among current users and lowering consumption among those who continue to use. For the remaining six concluding statements the evidence was strong (four statements) or limited (two statements).
Conclusions
The evidence presented and assessed in IARC Handbook volume 14 documents the effectiveness of tax and price policies in the control of tobacco use and improvement of public health.
Top-30
Journals
10
20
30
40
50
60
70
80
|
|
Tobacco Control
77 publications, 18.69%
|
|
Nicotine and Tobacco Research
35 publications, 8.5%
|
|
International Journal of Environmental Research and Public Health
14 publications, 3.4%
|
|
BMC Public Health
13 publications, 3.16%
|
|
PLoS ONE
12 publications, 2.91%
|
|
American Journal of Public Health
11 publications, 2.67%
|
|
Addiction
11 publications, 2.67%
|
|
BMJ Open
11 publications, 2.67%
|
|
Preventive Medicine
10 publications, 2.43%
|
|
American Journal of Preventive Medicine
8 publications, 1.94%
|
|
Journal of Public Health Management and Practice
5 publications, 1.21%
|
|
Frontiers in Public Health
4 publications, 0.97%
|
|
Preventive Medicine Reports
4 publications, 0.97%
|
|
SSRN Electronic Journal
4 publications, 0.97%
|
|
International Journal of Drug Policy
4 publications, 0.97%
|
|
Drug and Alcohol Dependence
4 publications, 0.97%
|
|
Preventing chronic disease
3 publications, 0.73%
|
|
Addictive Behaviors
3 publications, 0.73%
|
|
Public Health
3 publications, 0.73%
|
|
Revue des Maladies Respiratoires Actualites
3 publications, 0.73%
|
|
Health Economics (United Kingdom)
3 publications, 0.73%
|
|
Journal of the Korean Society for Research on Nicotine and Tobacco
3 publications, 0.73%
|
|
Cancer Epidemiology Biomarkers and Prevention
3 publications, 0.73%
|
|
American Journal of Health Economics
2 publications, 0.49%
|
|
American Journal of Health Promotion
2 publications, 0.49%
|
|
Scandinavian Journal of Public Health
2 publications, 0.49%
|
|
Cancer Causes and Control
2 publications, 0.49%
|
|
Israel Journal of Health Policy Research
2 publications, 0.49%
|
|
Canadian Journal of Public Health
2 publications, 0.49%
|
|
10
20
30
40
50
60
70
80
|
Publishers
10
20
30
40
50
60
70
80
90
|
|
BMJ
89 publications, 21.6%
|
|
Elsevier
72 publications, 17.48%
|
|
Springer Nature
48 publications, 11.65%
|
|
Oxford University Press
41 publications, 9.95%
|
|
Wiley
23 publications, 5.58%
|
|
MDPI
16 publications, 3.88%
|
|
Public Library of Science (PLoS)
13 publications, 3.16%
|
|
American Public Health Association
11 publications, 2.67%
|
|
SAGE
11 publications, 2.67%
|
|
Ovid Technologies (Wolters Kluwer Health)
9 publications, 2.18%
|
|
Taylor & Francis
7 publications, 1.7%
|
|
Cold Spring Harbor Laboratory
6 publications, 1.46%
|
|
Frontiers Media S.A.
5 publications, 1.21%
|
|
Social Science Electronic Publishing
4 publications, 0.97%
|
|
Cambridge University Press
4 publications, 0.97%
|
|
Centers for Disease Control and Prevention (CDC)
3 publications, 0.73%
|
|
The Korean Society for Research on Nicotine and Tobacco
3 publications, 0.73%
|
|
American Association for Cancer Research (AACR)
3 publications, 0.73%
|
|
University of Chicago Press
2 publications, 0.49%
|
|
Emerald
2 publications, 0.49%
|
|
S. Karger AG
2 publications, 0.49%
|
|
Mary Ann Liebert
2 publications, 0.49%
|
|
World Health Organization
2 publications, 0.49%
|
|
American Medical Association (AMA)
2 publications, 0.49%
|
|
European Publishing
2 publications, 0.49%
|
|
American Thoracic Society
1 publication, 0.24%
|
|
National Tax Association
1 publication, 0.24%
|
|
MIT Press
1 publication, 0.24%
|
|
American Academy of Pediatrics
1 publication, 0.24%
|
|
10
20
30
40
50
60
70
80
90
|
- We do not take into account publications without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.